Who owns BCRX
296 institutions reported holding BCRX for 2026Q1, together 102% of the company, more than the 268 a quarter earlier.
296
Institutions reporting a position · as of 2026Q1 · up from 268 the quarter before
- Shares held by institutions
- 246.7M
Shares held by institutions · 102% of the company · long US equity positions only, as reported on Form 13F
- Reported value
- $2.35B
Reported value · at 2026-03-31 prices, not today's
- Top 5 holders
- 37%
Top 5 holders · of the whole company, between five filers
Details›
- Reporting quarter2026-03-31
- 2026Q1
- Quarters on record
- 52
- New positions
- 65
- Positions exited
- 43
- Added to
- 112
- Reduced
- 71
- Top 10 holdersof the company
- 54%
| Quarter | Filers | Shares | Reported value |
|---|---|---|---|
| 2026Q1 | 296 | 246.7M | $2.35B |
| 2025Q4 | 268 | 212.1M | $1.65B |
| 2025Q3 | 282 | 194.1M | $1.48B |
| 2025Q2 | 289 | 197.1M | $1.77B |
| 2025Q1 | 271 | 174.7M | $1.32B |
| 2024Q4 | 257 | 167.7M | $1.26B |
| 2024Q3 | 255 | 173.1M | $1.32B |
| 2024Q2 | 239 | 174.4M | $1.08B |
| 2024Q1 | 235 | 180.0M | $915M |
| 2023Q4 | 234 | 176.9M | $1.06B |
| 2023Q3 | 232 | 175.8M | $1.24B |
| 2023Q2 | 235 | 174.1M | $1.23B |
| 2023Q1 | 239 | 170.3M | $1.42B |
| 2022Q4 | 227 | 156.7M | $1.80B |
| 2022Q3 | 233 | 148.6M | $1.87B |
| 2022Q2 | 219 | 151.9M | $1.61B |
| Holder | Shares | % of company | Value |
|---|---|---|---|
| VANGUARD GROUP INC | 24.4M | 10% | $232M |
| BlackRock Inc. | 22.7M | 9.3% | $216M |
| RA CAPITAL MANAGEMENT, L.P. | 15.8M | 6.5% | $151M |
| DEERFIELD MANAGEMENT CO /NY | 15.0M | 6.2% | $143M |
| STATE STREET CORP | 12.2M | 5.0% | $116M |
| TCG Crossover Management, LLC | 11.0M | 4.5% | $105M |
| HENDERSON GROUP PLC | 8.9M | 3.7% | $85M |
| PERCEPTIVE ADVISORS LLC | 7.4M | 3.1% | $71M |
| Vestal Point Capital, LP | 7.0M | 2.9% | $67M |
| TWO SIGMA INVESTMENTS, LP | 6.4M | 2.6% | $61M |
SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.
reading the register…
Drug Manufacturers - Specialty & Generic
Ranks #2 of 28 by Smart Score